Latest biomarker News

Prevention towards unwanted side effects of cancer treatment in children
£1.5m gift from Simon Sadler enables provision of new bursary for care leavers
The HILPAprotein: A potential biomarker for new treatment options in aggressive kidney cancer
The HILPDA Protein: A Potential Biomarker for New Treatment Options in aggressive Kidney Cancer
‘Cancer-cooling’ protein puts bowel cancer on ice 
ChemPartner Unveils Highly Anticipated Biology Database
Chronic migraine research finds genetic mechanism to lower migraine frequency
Alterity Therapeutics raises $4.8 million in new placement
Enhertu demonstrated clinically meaningful survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Detecting Parkinson’s disease decades before symptoms appear
AstraZeneca research reveals unique associations between rare changes in genes and plasma proteins that could improve drug discovery with data from over…
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
Actinogen CMO presents academic poster to Alzheimer’s Association International Conference
First patient dosed in study of TLX250-CDx exploring indication expansion
Mater Researchers shine fluorescent light on men’s health outcomes
Enhertu demonstrated clinically meaningful and durable responses in patients across multiple HER2-expressing advanced solid tumours
Pharmaxis reports positive results from trial of PXS‐6302
A novel biomarker and potential improved therapy for multiple sclerosis and related neurodegenerative disorders
Acid Glia in REM sleep: Stronger Acid Response in Epileptic Mice
Salt, calcium and vitamin D – do you get enough, or too much?
Capivasertib plus Faslodex reduced risk of disease progression or death by 40% versus Faslodex
Severe Covid risk elevated by high triglyceride level
AstraZeneca aims to redefine breast cancer care with new data across treatment spectrum at SABCS 2022
Researchers may have found new biomarker for acute Covid
TheraP biomarker analysis
NATURE publishes data on DUNP19 receptors role in cancer growth
Imugene doses first patient in nextHERIZON Phase 2 clinical trial
Covid disruptions take heavy toll on those with type 2 diabetes
Training Virtually Can Reduce Psychosocial Stress and Anxiety
When it comes to ADHD and ASD, the eyes could reveal all
Fast Five with Dr David Chieng
INOViQ announces manufacturing agreement with MP Biomedicals
Enhertu granted Priority Review in US for patients with previously treated HER2-mutant metastatic non-small cell lung cancer
Fast Five with Dr Alin Rai
Easy test can see if breeding bulls have right stuff
Women Hit by Myalgic Encephalomyelitis Chronic Fatigue Syndrome
Treating Intractable Diarrhea in Calves and Improving Intestinal Microflora
Lynparza plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic
New benchmark report provides accurate ID of variants in medically-relevant genes
Constant tinnitus is linked to altered brain activity
New BARD1 exosome liquid biopsy agreement with Griffith University
New drug offers hope for pancreatic cancer patients
Cell fitness used to determine outcomes in COVID patients
Billion year soul-burning puzzle: who made cheilanthanes?
New biomarker for severe Covid
Researcher discovers first brain marker for an anxiety disorder
Tasmanian medical researchers share in national funding
Biomarker identified to help predict atrial fibrillation in at-risk groups